Oxford PharmaGenesis appoints new Principal Medical Writer

10 January 2019

Now over 250 strong, the award-winning, independent HealthScience communications consultancy Oxford PharmaGenesis is pleased to announce the appointment of Corin Wing as Principal Medical Writer.

Corin, who has a background in medical research, is an accomplished writer who has worked across a broad range of therapy areas, strategic initiatives and deliverables.

She brings experience in medical writing from Ogilvy 4D, 7.4 Limited, Abacus International and most recently Envision Pharma, where she served as Principal Medical Writer from 2016.

Corin said: “I am thrilled to be joining such a dynamic and pioneering organization, who truly value their staff and set out to make a real difference for patients. Importantly, they also strive to enhance the discipline of medical communications by freely offering their extensive knowledge, leadership and support at events such as the European ISMPP meeting that takes place later this month. I am very excited to be part of this.”

Oxford PharmaGenesis CEO, Chris Winchester, said: “I am delighted to welcome Corin. Our motto is ‘Powerful thinking, dedicated to your success’, so it’s great that another talented writer has joined our expanding team delivering superlative service to all our clients.”